Glu also activates G-protein-coupled receptors
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(GPCRs) called metabotropic Glu receptors (mCluRs) that modulate the activity of enzymes producing second messengers such as phospholipase C (PLC), adenylyl cyclase (AC) and phospholipase A 2 (PLA2). They also activate or inhibit ion channels such as voltage-sensitive Ca2+ and K + channels. Moreover, they modulate the activity of ligand-gated channels such as the y-amino isobutyric acid-A, AMPA and NMDA receptors. Activation of mGluRs can therefore modulate and even mediate Glu-ergic neurotransmission in the brain (for a review, see [3] ).
The cloning of cDNAs encoding mGluRs revealed a large family of receptors having no sequence similarity with any other known GPCRs [4-91. So far, seven genes coding for mGluRs have been described, giving rise to mGluR1-7 (for a review, see [3] ). Based on their amino acid sequence identity, pharmacology and transduction mechanisms, they can be sub-classified into three groups (Figure 1 ). mGluR1 and mGluR5 which represent the first group, are coupled to PLC, and have quisqualate (Quis) as their most potent agonist. The second group is composed of mGluR2 and mGluR3, which inhibit AC and have (2S, 1'S,2'S)2-(carboxycyclopropyI)glycine (L-CCG-I) as their most potent agonist. The others, mGluR4, mGluR6 and mGluR7, correspond to the third group; they also inhibit AC but are selectively activated by ~-amino-4-phosphonobutyrate (L-AP4). Multiplicity in this receptor family is augmented by the existence of splice variants (for a review, see [3] Gd ' + 1 receptor that has only one transmembrane domain, has been shown to be coupled to Gi-proteins via a small segment of its C-terminal cytoplasmic domain [24] . Exchange of this segment with the C-terminal part of the third intracellular loop of the B2-adrenergic receptor generates a chimeric receptor able to activate AC [25] . This result confirmed that a single small segment in GPCR is essential for the specific activation of G-proteins.
The third intracellular loop of all mGluRs is short and is the most conserved intracellular domain, making it unlikely to be involved in the spedficity of activation of G-proteins. A main difference between mGluRs negatively coupled to AC and those coupled to PLC is the length of their C-terminal intracellular domain. The very long C-terminal domain found only in PLC-coupled mGluRs (mGluR1 and 5) is, however, probably not involved in the specific interaction with PLC-activating G-proteins, as two alternatively spliced forms of mGluR1 (mGluRlb and c) which lack this domain can also activate PLC [6, 26] .
By constructing chimeric receptors between mGluRlc and mGluR3 we have examined the role played by the intracellular domains of mGluRlc in determining its specific coupling to PLC.
Materials and methods

Nomenclature of chimeric receptors
The chimeric receptor names are RX/Y-(A,B, . . .), where X is the mGluR type in which small portions have been exchanged with those of mGluRY. The fragments exchanged are indicated in the parentheses and described in Figure 2 . For example, R3/1-(i2) is a chimeric mGluR3 receptor containing the second intracellular loop of mGluR1. When necessary, the subtype of alternatively spliced mGluR is specified. For example, as the C-terminal region of mGluRla, b and c are different, R3/lc-(C2) means that the entire C-terminal intracellular end of mGluR3 has been replaced by that of mGluR 1 c.
Construction of chimeric receptors
Chimeras were constructed using the PCR overlap-extension method [27] as previously described [28] . After construction, segments of the chimeric receptor DNA generated by PCR were sequenced on both strands using 17-25-mer primers with the dideoxynucleotide method using Sequenase (United States Biochemical).
Expression into Xenopus oocytes
The in vitro synthesis of cRNA from the cloned Volume 
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Figure 2
Sequence alignment of the intracellular loops of cloned mGluRs and of BoPCaR I
The loop located between TMD I and II is called i I. Loop i2 is located between TMD 111 and IV, and loop i3 between TMD V and VI. The sequence located downstream of TMD VII is referred t o as i4. Conserved residues among most mGluRs are boxed. Residues which are conserved only in mGluRs negatively coupled t o AC (mGluR2-4, 6 and 7) are boxed in black. Underlined residues in the BoPCaRl sequence correspond t o residues found in at least one mGluR. Gaps are indicated by '-I. Underlined in i2 is the C-terminal part of this loop which has t o be exchanged between mGluR3 and mGluRl t o allow R3/1 chimeric receDtor t o activate PLC. Underlined in i4 is the N-terminal segment termed C4. 
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cDNA, the preparation and recording of oocytes were as previously described [26] .
Results and discussion
Alignment of the intracellular loop sequences of the seven cloned mCluRs reveals that both il and i2 contain several amino acid residues which are conserved in the PLC-coupled mCluRs (mCluR2-4, 6
and 7 ) (Figure 2 ). The sequence of the intracellular domain located downstream of TMD VII (i4) is more variable in AC-coupled mGluRs, but highly conserved in PLC-coupled mGluRs. Interestingly, the il and i3 sequences of the PLC-coupled BoPCaRl are more homologous to those of ACcoupled mGluRs (Figure 2 ), making it unlikely that these loops play a critical role in the specificity of PLC coupling. Regions involved in the specific recognition of G-proteins in most GPCRs are likely to be amphiphilic a-helices [21, 22, 29, 30] . In the PLC-coupled mCluRs, both the N-and C-terminal domains of i2 and the segment located downstream of TMD VII have a high a-helix amphipathicity value. These amphipathic segments contain many basic residues (Figure 2 ) and therefore fulfil the criteria established for G-protein-activation domains of CPCRs [23] .
T o test the possibility that putative amphiphilic a-helices of mCluRs are involved in the specific activation of G-proteins, we constructed chimeric receptors between mCluR3 and mGluRlc, a truncated isoform of mGluRla which has a C-terminal intracellular domain similar in length to that of AC-coupled mGluRs [26] . The ability of the resulting chimeric receptors to activate PLC upon Glu stimulation was examined after expression into Xenopus oocytes. In these cells, it is well established that among GPCRs, only those coupled to PLC activate Ca2+-dependent C1-channels by releasing Ca2+ from internal stores [31] .
As previously reported, mCluRl c clearly activates a C1-current when expressed into oocytes [26] , and, as expected, the AC-coupled mGluR3 does not generate such a response (Figure 3) . Replacing i2 of mGluR3 with that of mGluRl is not sufficient to enable chimeric receptor R3/1-(i2) to activate PLC. Similarly, chimeric receptor R3/ 1 c- (C2), which possesses the C-terminal intracellular domain of mGluRlc, does not activate PLC. However, when both i2 and the C-terminal domain are exchanged between mGluR3 and mGluRlc, the resulting chimeric receptor R3/ 1-(i2,C2) induces an inward current when activated by Glu (Figure 3) . We have also replaced the second intracellular loop of mGluRla and mGluRlc with that of mGluR3. These chimeric receptors no longer activate PLC, indicating that i2 is important for the specific coupling to PLC. In order to delineate more precisely the region in i2 and in the C-terminal domain involved in the specific activation of PLC-coupled G-protein, new chimeric receptors containing only part of these domains were constructed. We found that only the chimeras containing the 16 C-terminal residues of mGluR1 i2 (Figures 2 and 3) can activate PLC. Although chimeric receptors containing the 19 N-terminal residues of the intracellular tail of mGluR1 (C4 segment; see Figure 2 ) activate the CI-current, the responses are always very small.
Only when the 28 N-terminal residues of this mGluR1 tail (C5 segment corresponding to the i4 sequence presented on Figure 2 ) are present is the chimeric receptor clearly coupled to PLC ( Figure   As mentioned earlier, only a small segment in the entire sequence of GPCR is probably sufficient to activate G-proteins. A discrete segment in i3 has been shown to play the critical role in determining the transduction mechanism of GPCRs [13, 14, 16, 17, 32] . Moreover, amphiphilic peptides like mastoparan [30, 33] , and peptides derived from the GPCR intracellular loop sequences [ 19, [21] [22] [23] 34, 35] have been shown to directly activate G-proteins. Therefore, only one of the two segments of mGluRs, i2 or the N-terminal part of the cytoplasmic tail, may play a critical role in the activation of G-proteins. T o examine this possibility, a set of new chimeric receptors was constructed in which il, i2, i3 and the C-terminal domain of mGluR3, alone or in different combinations, were replaced by the equivalent domains of mGluRlc. Most of the chimeric receptors that do not have i2 of mGluR1 are not able to activate PLC when expressed into Xenopus oocytes, indicating that i2 is necessary for the activation of PLC. The chimeric receptors R3/ l-(i2, i3) and R3/ 1 -(i 1, i2, i3), corresponding to mGluR3 that have i2 and i3, or i l , i2 and i3 of mGluR1 respectively, activate PLC in Xenopw oocytes (Figure 3 ). These data indicate that the N-terminal part of the cytoplasmic tail is not necessary for the activation of PLC. They also demonstrate that although i2 plays a critical role, other intracellular domains including i3 and the N-terminal part of the cytoplasmic tail of mGluRs are involved in the interaction with the G-proteins.
The coupling of mGluRlc to PLC in Xenopus oocytes is inhibited by Pertussis toxin [26] which ADP-ribosylates G-proteins of the Go and Gi type. Similarly, responses induced by R3/1-(i2,C5) or R3/1-(i2d, C5) are inhibited by this toxin, suggesting that these chimeric receptors interact, at least in part, with the same G-proteins as mGluR1 to activate PLC.
The pharmacology of R3/1 chimeras differs from that of mGluRl in that Quis which is the most potent agonist of mGluR1 has a low potency on R3/ 1 chimeras. Moreover, the mGluR2/3 agonist L-CCG-I [36] , which has a low potency on mGluRl, potently activates these chimeric receptors. The EC,,s determined for I,-CCG-I (1 pM), Glu (4.5 pM), ibotenate (1 5 pM), (1 S, 3S)ACPD In conclusion, by constructing chimeric mGluRs, we demonstrated that i2 plays an important role in determining the transduction mechanism of mGluRs. Although this domain does not appear to be sufficient, it may play a role similar to that of i3 in other seven-TMD receptors. Although no consensus sequence has been found for receptor domains involved in the activation of G-proteins, we found that the general characteristics of these domains -i.e. their probable amphiphilic a-helical structure, and the presence of several basic residues -are fulfilled in mGluRs. Taken together, our results confirm the proposed seven-TMD structure of mGluRs. . The molecular mechanism of action of all these different compounds has therefore been unknown. However, several recent studies, which will be discussed here, have now shed some light on to the mechanisms that underlie the high-affinity interaction of different
